Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes

Gina M. Doody, Daniel D. Billadeau, Elizabeth Clayton, Amanda Hutchings, Robert Berland, Simon McAdam, Paul J. Leibson, Martin Turner

Research output: Contribution to journalArticlepeer-review

61 Scopus citations


We show here that Vav-2 is tyrosine phosphorylated following antigen receptor engagement in both B- and T-cells, but potentiates nuclear factor of activated T cells (NFAT)-dependent transcription only in B cells. Vav-2 function requires the N-terminus, as well as functional Dbl homology and SH2 domains. Moreover, the enhancement of NFAT-dependent transcription by Vav-2 can be inhibited by a number of dominant-negative GTPases. The ability of Vav-2 to potentiate NFAT-dependent transcription correlates with its ability to promote a sustained calcium flux. Thus, Vav-2 augments the calcium signal in B cells but not T cells, and a truncated form of Vav-2 can neither activate NFAT nor augment calcium signaling. The CD19 co-receptor physically interacts with Vav-2 and synergistically enhances Vav-2 phosphorylation induced by the B-cell receptor (BCR). In addition, we found that Vav-2 augments CD19-stimulated NFAT-dependent transcription, as well as transcription from the CD5 enhancer. These data suggest a role for Vav-2 in transducing BCR signals to the transcription factor NFAT and implicate Vav-2 in the integration of BCR and CD19 signaling.

Original languageEnglish (US)
Pages (from-to)6173-6184
Number of pages12
JournalEMBO Journal
Issue number22
StatePublished - Nov 15 2000


  • CD 19
  • Lymphocyte
  • RhoG
  • Signaling
  • Vav

ASJC Scopus subject areas

  • General Neuroscience
  • Molecular Biology
  • General Biochemistry, Genetics and Molecular Biology
  • General Immunology and Microbiology


Dive into the research topics of 'Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes'. Together they form a unique fingerprint.

Cite this